| Literature DB >> 28481313 |
Ying Wang1,2, Hong-Xin Liu3, Yu-Chan Chen4, Zhang-Hua Sun5, Hao-Hua Li6, Sai-Ni Li7, Ming-Li Yan8, Wei-Min Zhang9.
Abstract
Two new compounds isobenzofuranone A (1) and indandione B (2), together with eleven known compounds (3-13) were isolated from liquid cultures of an endophytic fungus Alternaria sp., which was obtained from the medicinal plant Morinda officinalis. Among them, the indandione (2) showed a rarely occurring indanone skeleton in natural products. Their structures were elucidated mainly on the basis of extensive spectroscopic data analysis. All of the compounds were evaluated with cytotoxic and α-glucosidase inhibitory activity assays. Compounds 11 and 12 showed significant inhibitory activities against four tumor cell lines; MCF-7, HepG-2, NCI-H460 and SF-268, with IC50 values in the range of 1.91-9.67 μM, and compounds 4, 5, 9, 10, 12 and 13 showed excellent inhibitory activities against α-glucosidase with IC50 values in the range of 12.05-166.13 μM.Entities:
Keywords: Alternaria sp.; Morinda officinalis; cytotoxicity; endophytic fungus; α-glucosidase inhibitory
Mesh:
Substances:
Year: 2017 PMID: 28481313 PMCID: PMC6154570 DOI: 10.3390/molecules22050765
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of compounds 1–13 isolated from Alternaria sp. A744.
1H-NMR (500 MHz) and 13C-NMR (125 MHz) data for 1 and 2 in CD3OD.
| No. | 1 | 2 | ||
|---|---|---|---|---|
| δH ( | δC | δH ( | δC | |
| 1 | 171.2, C | 200.7, C | ||
| 2 | 73.8, C | |||
| 3 | 5.82 (dd, 8.0, 4.6) | 78.4, CH | 200.8, C | |
| 3a | 152.2, C | 143.4, C | ||
| 4 | 7.00 (d, 7.4) | 113.9, CH | 7.44 (d, 7.4) | 115.5, CH |
| 5 | 7.55 (dd, 8.2, 7.4) | 137.8, CH | 7.77 (dd, 8.2, 7.4) | 139.1, CH |
| 6 | 6.90 (d, 8.2) | 117.1, CH | 7.28 (d, 8.2) | 124.4, CH |
| 7 | 158.4, C | 158.3, C | ||
| 7a | 112.5, C | 127.4, C | ||
| 8 | 3.08 (dd, 16.6, 4.6) | 40.0, CH2 | 3.37 (d, 2.5) | 49.5, CH2 |
| 2.80 (dd, 16.6, 8.0) | ||||
| 9 | 171.5, C | 208.1, C | ||
| 10 | 3.72 (s) | 52.4, CH3 | 2.09 (s) | 29.3, CH3 |
Figure 2Key 1H-1H COSY () and HMBC () correlations for compounds 1, 2.
Cytotoxic activity of compounds 1–13.
| Compounds | IC50 (μM) | |||
|---|---|---|---|---|
| MCF-7 | HepG-2 | NCI-H460 | SF-268 | |
| ≥100 | ≥100 | ≥100 | ≥100 | |
| 35.73 ± 1.61 | 52.38 ± 2.46 | 43.31 ± 1.75 | 49.04 ± 1.84 | |
| ≥100 | ≥100 | ≥100 | ≥100 | |
| 3.73 ± 0.33 | 5.30 ± 0.95 | 5.47 ± 0.26 | 6.57 ± 0.35 | |
| 1.91 ± 0.17 | 5.63 ± 0.10 | 9.67 ± 0.22 | 4.25 ± 0.01 | |
| ≥100 | ≥100 | ≥100 | ≥100 | |
| Cisplatin | 3.09 ± 0.27 | 1.39 ± 0.18 | 2.43 ± 0.15 | 2.37 ± 0.35 |
α-Glucosidase inhibitory activities of compounds 4, 5, 9, 10, 12 and 13.
| Compounds | α-glucosidase (IC50, μM) |
|---|---|
| 34.88 ± 1.59 | |
| 102.34 ± 2.45 | |
| 141.43 ± 7.66 | |
| 74.94 ± 2.70 | |
| 12.05 ± 2.06 | |
| 166.13 ± 2.81 | |
| Acarbose | 427.34 ± 12.03 |